Anti-inflammatory activity of hyperoside through the suppression of nuclear factor-κB activation in mouse peritoneal macrophages

American Journal of Chinese Medicine

Volumn 39, Issue 1, 2011, Pages 171-181

  Kim, Su Jin ^a   Um, Jae Young ^a   Hong, Seung Heon ^b   Lee, Ju Young ^c  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Shinsung University   (South Korea)

Author keywords

Hyperoside; Interleukin 6; Nitric Oxide; Nuclear Factor Kappa B; Tumor Necrosis Factor

Indexed keywords

HYPERIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; DRUG ACTIVITY; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANGIOSPERMS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CRATAEGUS; HYPERICUM; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; NF-KAPPA B; NITRIC OXIDE; PLANT EXTRACTS; QUERCETIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751486553     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11008737     Document Type: Article

References (31)

1. Beutler, B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43: 227-235, 1995.
2. Beutler, B. TNF, immunity and inflammatory disease: lessons of the past decade. Curr. Opin. Immuno. 12: 20-26, 2000.
3. Dinarello, C.A. Proinflammatory cytokines. Chest. 118: 503-508, 2000.
4. Ghosh, S., M.J. May and E.B. Kopp. NF-B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260, 1998.
5. Grosjean, S.A., M.A. Arstall, R.N. Mitchell, G.W. Klappacher, R.A. Kelly, M.A. Pfeffer and J.M. Pfeffer. Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection. J. Card. Fail. 5: 236-245, 1999.
6. Harbrecht, B.G., T.R. Billiar, J. Stadler, A.J. Demetris, J.B. Ochoa, R.D. Curran and R.L. Simmons. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit. Care Med. 20: 1568-1574, 1992.
7. Hawiger, J. Innate immunity and inflammation: a transcriptional paradigm. Immunol. Res. 23: 99-109, 2001.
8. Hu, J., Z. Wang, Y.Y. Guo, X.N. Zhang, Z.H. Xu, S.B. Liu, H.J. Guo, Q. Yang, F.X. Zhang, X.L. Sun and M.G. Zhao. A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain. Mol. Pain 12: 71, 2009.
9. Huang, Y., J. Li, X.M. Meng, G.L. Jiang, H. Li, Q. Cao, S.C. Yu, X.W. Lv and W.M. Cheng. Effect of triterpene acids of Eriobotrya japonica (Thunb.) Lindl. leaf and MAPK signal transduction pathway on inducible nitric oxide synthase expression in alveolar macrophage of chronic bronchitis rats. Am. J. Chin. Med. 37: 1099-1111, 2009.
10. Kopp, E. and S. Ghosh. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959, 1994.
11. Lappas, M., M. Permezel, H.M. Georgiou and G.E. Rice. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 67: 668-673, 2002.
12. Leiro, J.M., E. Alvarez, J.A. Arranz, E. Cano and F. Orallo. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages. Immunopharmacology 4: 163-177, 2004.
13. Lind, L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169: 203-214, 2003.
14. Liu, Z., X. Tao, C. Zhang, Y. Lu and D. Wei. Protective effects of hyperoside (quercetin-3-ogalactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. Biomed Pharmacother. 59(9): 481-490, 2005.
15. MacMicking, J., Q.W. Xie and C. Nathan. Nitric oxide and macrophage function. Ann. Rev. Immunol. 15: 323-350, 1997.
16. Medzhitov, R. and C.A. Jr. Janeway. Innate immunity: the virtues of a nonclonal system of recognition. Cell 9: 295-298, 1997.
17. Narumi, S., J.H. Finke and T.A. Hamilton. Interferon gamma and interleukin-2 synergize to induce selective monokine expression in murine peritoneal macrophages. J. Biol. Chem. 265: 7036-7041, 1990.
18. Parrillo, J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328: 1471-1477, 1993.
19. Petros, A., G. Lamb, A. Leone, S. Moncada, D. Bennett and P. Vallance. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39, 1994.
20. Piao, M.J., K.A. Kang, R. Zhang, D.O. Ko, Z.H. Wang, H.J. You, H.S. Kim, J.S. Kim, S.S. Kang and J.W. Hyun. Hyperoside prevents oxidative damage induced by hydrogen peroxide in lung fibroblast cells via an antioxidant effect. Biochim, Biophys, Acta. 1780(12): 1448-1457, 2008.
21. Pfeilschifter, J. and H. Muhl. Immunopharmacology: anti-inflammatory therapy targeting transcription factors. Eur. J. Pharmacol. 30: 237-245, 1999.
22. Stark, L.A., F.V. Din, R.M. Zwacka and M.G. Dunlop. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15(7): 1273-1275, 2001.
23. Scherer, D.C., J.A. Brockman, Z. Chen, T. Maniatis and D.W. Ballard. Signal-induced degradation of IkBa requires site-specific ubiquitination. Proc. Natl. Acad. Sci. 92: 11259-11263, 1995.
24. Schoonbroodt, S., S. Legrand-Poels, M. Best-Belpomme and J. Piette. Activation of the NF-B transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J. 321: 777-785, 1997.
25. Stevens, C., G. Walz and C. Singaram. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin- 6 expression in inflammatory bowel disease. Dig. Dis. Sci. 37: 818-826, 1992.
26. Tegeder, I., J. Pfeilschifter and G. Geisslinger. Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J. 15: 2057-2072, 2001.
27. Thanos, D. and T. Maniatis, NF-kB: a lesson in family values. Cell 80: 529-532, 1995.
28. Vainas, T., F.R. Stassen, R. de Graaf, E.L. Twiss, S.B. Herngreen, R.J. Welten, L.H. van den Akker, M.P. van Dieijen-Visser, C.A. Bruggeman and P.J. Kitslaar. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J. Vasc. Sur. 42: 243-251, 2005.
29. Vallance, P. and S. Moncada. Role of endogenous nitric oxide in septic shock. New Horiz. 1: 77-86, 1993.
30. Weinberg, J.B., M.A. Misukonis, P.J. Shami, S.N. Mason, D.L. Sauls, G.K. Smith, B. McDonald and K.E. Bachus. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195, 1995.
31. Wu, L.L., X.B. Yang, Z.M. Huang, H.Z. Liu and G.X. Wu. In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik. Acta. Pharmacol. Sin. 28(3): 404-409, 2007.